Qubti MA, Flynn JA. Chapter 17. Ankylosing spondylitis & the arthritis of inflammatory bowel disease. In: Imboden JB, Hellmann DB, Stone JH, eds. Current diagnosis & treatment: rheumatology. 3rd ed. Nova York: McGraw‐Hill, 2013.
Bikle DD. What is new in vitamin D: 2006‐2007. Curr Opin Rheumatol. 2007 Jul;19:383‐8.
Gatenby, 2013, deficiency and risk for rheumatic diseases: an update, Curr Opin Rheumatol., 25, 184, 10.1097/BOR.0b013e32835cfc16
Lange, 2005, Association of 1.25 vitamin D3 deficiency, disease activity and low bone mass in ankylosing spondylitis, Osteoporos Int., 16, 1999, 10.1007/s00198-005-1990-5
Lange, 2001, Relationship between disease activity and serum levels of vitamin D metabolites and parathyroid hormone in ankylosing spondylitis, Osteoporos Int., 12, 1031, 10.1007/s001980170013
Mermerci Bas¸kan, 2010, The relation between osteoporosis and vitamin D levels and disease activity in ankylosing spondylitis, Rheumatol Int., 30, 375, 10.1007/s00296-009-0975-7
Arends, 2011, The relation between bone mineral density, bone turnover markers, and vitamin D status in ankylosing spondylitis patients with active disease: a crosssectional analysis, Osteoporos Int., 22, 1431, 10.1007/s00198-010-1338-7
Durmus, 2012, Does vitamin D affect disease severity in patients with ankylosing spondylitis?, Chin Med J (Engl)., 125, 2511
Erten, 2013, Decreased plasma vitamin D levels in patients with undifferentiated spondyloarthritis and ankylosing spondylitis, Intern Med., 52, 339, 10.2169/internalmedicine.52.9047
Hmamouchi, 2013, The relation between disease activity, vitamin D levels and bone mineral density in men patients with ankylosing spondylitis, Rheumatol Rep., 5, 7, 10.4081/rr.2013.e3
Yazmalar, 2013, Tekeoglu Seasonal disease activity and serum vitamin D levels in rheumatoid arthritis, ankylosing spondylitis and osteoarthritis, Afr Health Sci., 13, 47
Franck, 1993, Serum osteocalcin and vitamin D metabolites in patients with ankylosing spondylitis, Ann Rheum Dis., 52, 343, 10.1136/ard.52.5.343
Overbergh, 2000, Identification and immune regulation of 25‐hydroxyvitamin D‐1‐alpha‐hydroxylase in murine macrophages, Clin Exp Immunol., 120, 139, 10.1046/j.1365-2249.2000.01204.x
Cutolo, 2011, endocrine system involvement in autoimmune rheumatic diseases, Autoimmun Rev., 11, 84, 10.1016/j.autrev.2011.08.003
Chen, 2009, Biomarkers in spondyloarthropathies, Adv Exp Med Biol., 649, 122, 10.1007/978-1-4419-0298-6_9
Hakkou, 2012, Comparison of the BASDAI and the miniBASDAI in assessing disease activity in patients with ankylosing spondylitis, Clin Rheumatol., 31, 441, 10.1007/s10067-011-1872-5
Holick, 2007, Vitamin D deficiency, N Engl J Med., 357, 266, 10.1056/NEJMra070553
Holick, 2011, Endocrine Society. Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline, J Clin Endocrinol Metab, 96, 1911, 10.1210/jc.2011-0385
Mathieu, 2005, Vitamin D and diabetes, Diabetologia., 48, 1247, 10.1007/s00125-005-1802-7
Cutolo, 2009, Vitamin D involvement in rheumatoid arthritis and systemic lupus erythaematosus, Ann Rheum Dis., 68, 446, 10.1136/ard.2008.093476
Welsh, 2011, Is vitamin D in rheumatoid arthritis a magic bullet or a mirage? The need to improve the evidence base prior to calls for supplementation, Arthritis Rheum., 63, 1763, 10.1002/art.30341
Reid, 2010, Acute changes in the systemic inflammatory response is associated with transient decreases in circulating 25‐hydroxyvitamin D concentrations following elective knee arthoplasty, Ann Clin Biochem., 47, 95
Shany, 2001, The effects of 1 alpha, 24(S)‐dihydroxyvitamin D(2) analog on cancer cell proliferation and cytokine expression, Steroids., 66, 319, 10.1016/S0039-128X(00)00154-9
Song, 2012, Association between vitamin D intake and the risk of rheumatoid arthritis: a meta‐analysis, Clin Rheumatol., 31, 1733, 10.1007/s10067-012-2080-7
Tsiaras, 2011, Factors influencing vitamin D status, Acta Derm Venereol., 91, 115, 10.2340/00015555-0980